Toll/Interleukin-1 Receptor Domain Derived from TcpC (TIR-TcpC) Ameliorates Experimental Autoimmune Arthritis by Down-modulating Th17 Cell Response.
about
Toll/Interleukin-1 Receptor Domain Derived from TcpC (TIR-TcpC) Ameliorates Experimental Autoimmune Arthritis by Down-modulating Th17 Cell Response.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 March 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Toll/Interleukin-1 Receptor Do ...... modulating Th17 Cell Response.
@en
Toll/Interleukin-1 Receptor Domain Derived from TcpC
@nl
type
label
Toll/Interleukin-1 Receptor Do ...... modulating Th17 Cell Response.
@en
Toll/Interleukin-1 Receptor Domain Derived from TcpC
@nl
prefLabel
Toll/Interleukin-1 Receptor Do ...... modulating Th17 Cell Response.
@en
Toll/Interleukin-1 Receptor Domain Derived from TcpC
@nl
P2093
P2860
P356
P1476
Toll/Interleukin-1 Receptor Do ...... modulating Th17 Cell Response.
@en
P2093
Avadhesha Surolia
Shweta Pasi
P2860
P304
12358-12369
P356
10.1074/JBC.M116.722801
P407
P577
2016-03-28T00:00:00Z